BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
World's top technology exhibition CES 2021
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Daewoong seeks Philippine approval to test tapeworm treatment medicine

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : July 8, 2020, 15:51 | Updated : July 8, 2020, 15:51
  • 트위터
  • 페이스북
  • 웨이보

[Courtesy of Daewoong ]


SEOUL -- Daewoong Pharmaceutical, a major bioengineering company in South Korea, has applied for approval by a Philippine health regulatory agency to test niclosamide (DWRX2003), a tapeworm treatment medicine selected as a candidate for COVID-19 antibody treatment.

Daewoong said it has sent an investigational new drug (IND) application to the Food and Drug Administration of the Philippines. If approval comes, the company will go ahead with the first-stage clinical trial of DWRX2003 in the Southeast Asian country. A similar application was made in India in May.

Daewoong claimed to have achieved progress in the initial animal testing of niclosamide. Institut Pasteur Korea, an infectious disease-focused research institute, works with a subsidiary of Daewoong to test the efficacy of niclosamide, which basically starves tapeworms to death by inhibiting the glucose uptake, oxidative phosphorylation and anaerobic metabolism.

To find COVID-19 treatment, Daewoong is also testing the effectiveness of mesenchymal stem cells (MSCs) and camostat mesilate, a potent serine protease inhibitor sold under the brand of Foistar. Foreign studies showed that camostat mesilate was found to be effective in blocking the spread and pathogenesis of COVID-19 in animal testing.

 

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Preliminary approval to finance production of Daewoongs tapeworm treatment medicine  .
    Preliminary approval to finance production of Daewoong's tap…
  • .Daewoong allowed to test efficacy of tapeworm treatment medicine in Philippines.
    Daewoong allowed to test efficacy of tapeworm treatment medi…
  • .Daewoong to stage clinical trials of COVID-19 treatment using stem cells .
    Daewoong to stage clinical trials of COVID-19 treatment usin…
  • .Daewoong allowed to conduct third-stage combination therapy with diabetes drug candidate.
    Daewoong allowed to conduct third-stage combination therapy …
  • .Daewoong shares up in domestic market after 21-month ban by U.S. trade panel  .
    Daewoong shares up in domestic market after 21-month ban by …

Real Time Photo News

  • .Singer IU drops teaser image for upcoming full album.

    Singer IU drops teaser image for upcoming full album

  • .Cube Entertainment partners with web comics company to create online video content.

    Cube Entertainment partners with web comics company to create online video content

  • .Sci-fi film starring Song Joong-ki to be reelased on Netflix in February.

    Sci-fi film starring Song Joong-ki to be reelased on Netflix in February

  • .Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series Criminal Justice.

    Actor Kim Soo-hyun to star in S. Korean remake of British TV drama series 'Criminal Justice'

  • .CJ ENM partners with NCSoft to roll out new digital content for global market.

    CJ ENM partners with NCSoft to roll out new digital content for global market

Latest News

more+

  • Singer IU drops teaser image for upcoming full album
  • Hyundai to complete construction of fuel cell production plant in China in 2022
  • Seoul builds solar power plant on idle land near urban expressway
  • Samsung showcases new Galaxy S21 smartphone models
  • Southern city launches joint research project to develop heavy-duty flying taxi drone
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view